Related Experiment Video
Updated: May 26, 2025

09:00
Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors
Published on: August 18, 2016
7.6K
99m Tc-PSMA Scintigraphy of Subcutaneous Angiolipoma
Amin Saber Tanha1, Zahra Rafiei2, Nasrin Raeisi1
1Department of Nuclear Medicine Research Center.
Clinical Nuclear Medicine
|February 24, 2025
Summary
A prostate cancer patient had a false positive 99m Tc-PSMA scan due to an angiolipoma. This is the first reported case of PSMA scintigraphy detecting angiolipoma as a false positive finding.
Area of Science:
- Nuclear Medicine
- Oncology
- Pathology
Background:
- Prostate-specific membrane antigen (PSMA) scintigraphy is crucial for staging prostate cancer.
- False-positive findings can complicate diagnostic accuracy.
- Angiolipomas are benign tumors rarely encountered in PSMA imaging.
Purpose of the Study:
- To report a unique case of angiolipoma mimicking malignancy on PSMA scintigraphy.
- To highlight the potential for false-positive PSMA uptake in benign lesions.
- To emphasize the importance of histopathological correlation.
Main Methods:
- A 69-year-old man with prostate adenocarcinoma underwent 99m Tc-PSMA scintigraphy for staging.
- SPECT/CT imaging was used for lesion localization.
- Surgical excision and histopathological examination confirmed the diagnosis.
Main Results:
- PSMA scintigraphy showed focal uptake in the posterior abdominal wall.
- SPECT/CT confirmed a subcutaneous soft tissue lesion.
- Histopathology revealed the lesion to be an angiolipoma.
Conclusions:
- This is the first reported case of PSMA scintigraphy detecting an angiolipoma as a false positive.
- Angiolipomas should be considered in the differential diagnosis of focal PSMA uptake.
- Careful correlation with imaging and histopathology is essential for accurate diagnosis.

